Navigation Links
Washington University Becker Library Makes MetaCore Accessible Throughout the University
Date:2/10/2009

ST. JOSEPH, Mich., Feb. 10 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that Becker Medical Library at Washington University in St. Louis has licensed MetaCore. The Becker Medical Library Bioinformatics@Becker program is a university wide resource which provides bioinformatics support for researchers and students. MetaCore is an easy to use data mining tool that provides users with fast easy access to up to date pertinent pathway information. Researchers can run simple searches as well as very specific Boolean queries and have answers in seconds or minutes rather than weeks and months using traditional methods. MetaCore can also be used for pathway analysis of all kinds of experimental data from gene expression, micro RNA to assay data as well as biomarker studies

"Becker Medical Library at Washington University in St. Louis is an important customer for GeneGo as we build up the number of libraries using GeneGo products," said Julie Bryant, GeneGo's VP of Business development. "Libraries are the heart of most academic centers and an excellent resource for PI's, researchers and students where systems biology comes together with all types of experimental data, biologists, chemists and pharmacologists and therapeutic focuses."

About GeneGo, Inc.

GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flagship product, MetaCore 5.2(TM), assists pharmaceutical scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 5.2(TM) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase(TM) represents the knowledge base for MetaCore.

For more information, please visit the company's web site at www.genego.com.


'/>"/>
SOURCE GeneGo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AUDIO from Medialink and Pfizer: Prescription for Safer Drugs Discussed in Washington
2. Childrens Hospitals in Washington to Lobby Congress to Reauthorize SCHIP Now
3. Medicare Cuts to Physicians Will Harm Washington Seniors
4. Staying sharp in Washington, D.C.
5. Cardiac Science Named to Deloittes Technology Fast 50 for Washington State
6. Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloittes 2007 Washington State Technology Fast 50 for 4th Time in Past 6 Years
7. Washington Comes Together to Promote Smoking Cessation
8. A Breath of Fresh Air From Washington: Senate Passes Historic Asbestos Ban
9. Washington Capitals to Visit Patients at Childrens National Medical Center, Announce Launch of Initiative to Fight Pediatric Cancer
10. Are We Ready? Washington Hospital Center Sets Precedents in Preparedness for 9/11-Style Attacks
11. 14,000 Public Health Experts to Convene at American Public Health Association Annual Meeting in Washington, D.C.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: